Credit Suisse Ag Revolution Medicines, Inc. Call Options Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RVMD
# of Institutions
231Shares Held
161MCall Options Held
251KPut Options Held
133K-
Vanguard Group Inc Valley Forge, PA14.4MShares$651 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA13.7MShares$619 Million0.1% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$608 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.76MShares$442 Million1.83% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$343 Million3.9% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.97B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...